NCT02062749View on ClinicalTrials.gov

Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 19, 2014

Primary Completion Date

June 27, 2018

Study Completion Date

June 27, 2018

Conditions
Colorectal Cancer
Interventions
DRUG

Oxaliplatin

Starting dose of Oxaliplatin is 175 mg/m2 delivered by hyperthermic intraperitoneal chemotherapy over 90 minutes.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT02062749 - Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma | Biotech Hunter | Biotech Hunter